CompletedPhase 2ACTRN12614000004662

A single-blind randomised controlled trial of topical Kanuka honey for the treatment of Rosacea

In adult patients with rosacea will topical medical grade Kanuka honey reduce rosacea severity compared with Cetomacrogol control cream.

Sponsor

Honeylab Ltd

Enrollment

138 participants

Start Date

Feb 4, 2014

Study Type

Interventional

Conditions

Rosacea

Summary

A recent pilot study investigating the use and acceptability of Kanuka honey in Rosacea showed a reduction in severity in 70% of subjects, therefore this study treatment has the potential to be an effective treatment for Rosacea symptoms. In this study 138 adults with Rosacea will apply either Kanuka honey or Cetomacrogol cream to areas of Rosacea on their face for 30-60 minutes twice a day for 8 weeks. At baseline and after 2 weeks and 8 weeks the patient's Rosacea will be assessed to look at changes in severity. Participants will complete a diary for 8 weeks to record their daily treatment applications and weekly severity assessment. Subjects will complete a Dermatology Quality of Life questionnaire at all visits, to note any changes in quality of life. A visual analogue scale will be completed to note any improvement or worsening of a patient's rosacea at Visits 2 and 3. This study will investigate the effectiveness of Kanuka honey in treating rosacea, potentially improving the health outcomes of those with the condition, and will contribute to the knowledge base around the use of honey for the treatment of skin conditions.

Eligibility

Sex: Both males and femalesMin Age: 16 Yearss

Plain Language Summary

Simplified for easier understanding

This study is testing whether a topical cream containing Kanuka honey can treat rosacea, a chronic skin condition that causes redness and visible blood vessels on the face. Researchers are comparing the honey cream to a standard control cream to see which is more effective at reducing rosacea symptoms. You may be eligible if: - You are 16 years of age or older - Your rosacea severity score is 2 or greater at the start of the study You may NOT be eligible if: - You have used systemic corticosteroids in the last 4 weeks - You are currently using oral or topical antibiotics for rosacea - You are currently using topical corticosteroids for rosacea - You have a known or suspected allergy to honey or Cetomacrogol cream Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Topical medical grade Kanuka honey with 10% glycerin content applied to the affected facial area twice daily for 30-60 minutes per application, for eight weeks. A patient diary will record applicatio

Topical medical grade Kanuka honey with 10% glycerin content applied to the affected facial area twice daily for 30-60 minutes per application, for eight weeks. A patient diary will record applications during the treatment period.